Non-Responders to Treatment With Antibodies to the CGRP-Receptor May Profit From a Switch of Antibody Class
Standard
Non-Responders to Treatment With Antibodies to the CGRP-Receptor May Profit From a Switch of Antibody Class. / Ziegeler, Christian; May, Arne.
in: HEADACHE, Jahrgang 60, Nr. 2, 02.2020, S. 469-470.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › Andere (Vorworte u.ä.) › Forschung
Harvard
Ziegeler, C & May, A 2020, 'Non-Responders to Treatment With Antibodies to the CGRP-Receptor May Profit From a Switch of Antibody Class', HEADACHE, Jg. 60, Nr. 2, S. 469-470. https://doi.org/10.1111/head.13729
APA
Ziegeler, C., & May, A. (2020). Non-Responders to Treatment With Antibodies to the CGRP-Receptor May Profit From a Switch of Antibody Class. HEADACHE, 60(2), 469-470. https://doi.org/10.1111/head.13729
Vancouver
Ziegeler C, May A. Non-Responders to Treatment With Antibodies to the CGRP-Receptor May Profit From a Switch of Antibody Class. HEADACHE. 2020 Feb;60(2):469-470. https://doi.org/10.1111/head.13729
Bibtex
@article{d10a293a78a64279bd3c0da0e0e283ec,
title = "Non-Responders to Treatment With Antibodies to the CGRP-Receptor May Profit From a Switch of Antibody Class",
author = "Christian Ziegeler and Arne May",
note = "Letter",
year = "2020",
month = feb,
doi = "10.1111/head.13729",
language = "English",
volume = "60",
pages = "469--470",
journal = "HEADACHE",
issn = "0017-8748",
publisher = "Wiley-Blackwell",
number = "2",
}
RIS
TY - JOUR
T1 - Non-Responders to Treatment With Antibodies to the CGRP-Receptor May Profit From a Switch of Antibody Class
AU - Ziegeler, Christian
AU - May, Arne
N1 - Letter
PY - 2020/2
Y1 - 2020/2
U2 - 10.1111/head.13729
DO - 10.1111/head.13729
M3 - Other (editorial matter etc.)
C2 - 31872439
VL - 60
SP - 469
EP - 470
JO - HEADACHE
JF - HEADACHE
SN - 0017-8748
IS - 2
ER -
